Lars Krogvold
Overview
Explore the profile of Lars Krogvold including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
50
Citations
1534
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Buschard K, Jensen M, Krogvold L, Gerling I, Dahl-Jorgensen K, Pedersen K, et al.
Diabetes Metab Res Rev
. 2023 Jul;
39(7):e3678.
PMID: 37395313
Aims: To investigate if HLA risk haplotypes and HbA1c levels are associated with the expression levels of innate anti-viral immune pathway genes in type 1 diabetes. Materials And Methods: We...
12.
Josefsen K, Krogvold L, Gerling I, Pociot F, Dahl-Jorgensen K, Buschard K
Front Endocrinol (Lausanne)
. 2023 Jan;
13:1032822.
PMID: 36589856
Background: At diagnosis of Type 1 Diabetes (T1D), 30% of the beta cells are dormant, i.e. alive, but inactive. This could reduce beta cell destruction, as cellular stress contributes to...
13.
Sundberg F, deBeaufort C, Krogvold L, Patton S, Piloya T, Smart C, et al.
Pediatr Diabetes
. 2022 Dec;
23(8):1496-1511.
PMID: 36537520
No abstract available.
14.
Tekin H, Josefsen K, Krogvold L, Dahl-Jorgensen K, Gerling I, Pociot F, et al.
Sci Rep
. 2022 Oct;
12(1):18149.
PMID: 36307540
Type 1 diabetes (T1D) incidence is increased after COVID-19 infection in children under 18 years of age. Interferon-α-activated oligoadenylate synthetase and downstream RNAseL activation degrade pathogen RNA, but can also...
15.
Krogvold L, Leete P, Mynarek I, Russell M, Gerling I, Lenchik N, et al.
Front Endocrinol (Lausanne)
. 2022 Aug;
13:881997.
PMID: 35957810
Aims/hypothesis: The Diabetes Virus Detection (DiViD) study has suggested the presence of low-grade enteroviral infection in pancreatic tissue collected from six of six live adult patients newly diagnosed with type...
16.
Krogvold L, Genoni A, Puggioni A, Campani D, Richardson S, Flaxman C, et al.
Diabetologia
. 2022 Aug;
65(12):2108-2120.
PMID: 35953727
Aims/hypothesis: Enterovirus (EV) infection of pancreatic islet cells is one possible factor contributing to type 1 diabetes development. We have reported the presence of EV genome by PCR and of...
17.
Valikangas T, Lietzen N, Jaakkola M, Krogvold L, Eike M, Kallionpaa H, et al.
Front Endocrinol (Lausanne)
. 2022 May;
13:861985.
PMID: 35498413
Although type 1 diabetes (T1D) is primarily a disease of the pancreatic beta-cells, understanding of the disease-associated alterations in the whole pancreas could be important for the improved treatment or...
18.
Nigi L, Brusco N, Grieco G, Fignani D, Licata G, Formichi C, et al.
Front Immunol
. 2022 Apr;
13:833141.
PMID: 35359976
The interaction between genetic and environmental factors determines the development of type 1 diabetes (T1D). Some viruses are capable of infecting and damaging pancreatic β-cells, whose antiviral response could be...
19.
Oikarinen S, Krogvold L, Edwin B, Buanes T, Korsgren O, Laiho J, et al.
Diabetologia
. 2021 Aug;
64(11):2491-2501.
PMID: 34390364
Aims/hypothesis: The Diabetes Virus Detection (DiViD) study is the first study to laparoscopically collect pancreatic tissue and purified pancreatic islets together with duodenal mucosa, serum, peripheral blood mononuclear cells (PBMCs)...
20.
Zuijdwijk C, Vukovic R, Marks B, Mandilou S, Ng S, Wright N, et al.
Pediatr Diabetes
. 2021 Jul;
22(6):843-849.
PMID: 34240520
No abstract available.